BONE MARROW FAILURE
Clinical trials for BONE MARROW FAILURE explained in plain language.
Never miss a new study
Get alerted when new BONE MARROW FAILURE trials appear
Sign up with your email to follow new studies for BONE MARROW FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy aims to make risky cancer transplants safer
Disease control OngoingThis early-stage trial is testing whether adding specially treated immune cells, called 'veto cells,' can help patients with blood cancers or bone marrow disorders after a stem cell transplant from a half-matched donor. The goal is to help the donor's cells grow and work in the p…
Matched conditions: BONE MARROW FAILURE
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 22:41 UTC
-
Experimental cell therapy tested for rare genetic blood disorder
Disease control OngoingThis early-stage study is testing the safety of an experimental cell therapy called EXG34217 in people with genetic disorders that cause bone marrow failure. The therapy involves collecting a patient's own blood cells, modifying them in a lab to potentially lengthen their telomer…
Matched conditions: BONE MARROW FAILURE
Phase: PHASE1 • Sponsor: Elixirgen Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC